Strata Skin Sciences Q4 EPS $(0.04) Misses $(0.02) Estimate, Sales $8.69M Miss $10.01M Estimate
Portfolio Pulse from dijoy@benzinga.com
Strata Skin Sciences (NASDAQ:SSKN) reported Q4 earnings with a loss of $(0.04) per share, missing the $(0.02) estimate, and sales of $8.69M, missing the $10.01M estimate. This represents a significant decrease from the previous year.
March 27, 2024 | 8:52 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Strata Skin Sciences reported a larger than expected quarterly loss and a significant miss in sales, indicating a substantial year-over-year decline.
The reported earnings miss and sales shortfall are significant indicators of underperformance, likely leading to negative investor sentiment in the short term. The magnitude of the miss and the comparison to last year's figures suggest operational or market challenges that could impact investor confidence and stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100